Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
All news about JOHNSON & JOHNSON
10:31aMinerva Neurosciences to Sell Royalty Interest in Depressive Disorder Drug; S..
MT
01:09aJOHNSON & JOHNSON : Some Key Questions Answered On Covid-19 Vaccines for African..
AQ
01/18JOHNSON & JOHNSON : - DARZALEX FASPRO Becomes the First FDA-Approved Treatment f..
AQ
01/17FAUCI : U.S. 'weeks away' from evaluating new vaccine candidates
AQ
01/15JOHNSON & JOHNSON : DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) Become..
PU
01/15GENMAB A/S : to Receive $30 Million Milestone Payment from Janssen Over FDA Appr..
MT
01/15"MY 2021 HEALTHCARE RESOLUTION" : 7 Johnson & Johnson Leaders Share Their Goals ..
PU
01/14JOHNSON & JOHNSON : Statement on Political Contributions
PU
01/14NEXTECH AR : sees $7.3M in business for Q4
AQ
01/14US Stocks Rise in Early Trading Amid Expectations of Surge in Consumer Spendi..
MT
01/14Presidency On Africa Centres for Disease Control and Prevention Securing Firs..
AQ
01/14The earnings season picks up steam
01/14THE COVID-19 DATA PLAN : 3 Innovative Ways Johnson & Johnson Is Using Data Scien..
AQ
01/14Invitae to Develop Standardized Panel to Detect Molecular Residual Disease as..
MT
01/14270 Million Covid-19 Vaccine Doses Secured for Africa
AQ
01/13JOHNSON & JOHNSON : Favorable Data Published About Johnson & Johnson Covid-19 Va..
DJ
01/13MARKET CHATTER : Johnson & Johnson One Dose Covid-19 Vaccine Shown to Be Safe, G..
MT
01/13JOHNSON & JOHNSON : Shares Higher After-Hours - One-Dose Covid-19 Vaccine Report..
MT
01/13JOHNSON & JOHNSON : COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published..
PU
01/13JOHNSON & JOHNSON : African Union buys 270 million vaccine doses for continent
AQ
01/13J&J vaccine on track for March rollout with target to deliver 1 bln doses thi..
RE
01/13J&J COVID-19 vaccine on track for March rollout, still aims for 1 bln doses t..
RE
01/13ESSA PHARMA : Janssen to Pursue Clinical Collaboration in Prostate Cancer Combin..
MT
01/13GLOBAL MARKETS LIVE: Qualcomm, Boeing, Visa…
01/13JOHNSON & JOHNSON : Janssen to Highlight Commitment to Lung Cancer Science and I..
AQ
01/12J&J Opposes Former Talc Supplier's Bankruptcy Plan to Resolve Cancer Claims
DJ
01/12JOHNSON & JOHNSON : Janssen to Highlight Commitment to Lung Cancer Science and I..
PU
01/09The Cold Supply Chain Can't Reach Everywhere - That's a Big Problem for Equit..
AQ
01/08COVID-19 UPDATE : Your Latest Questions About Johnson & Johnson's Investigationa..
AQ
01/07The Vaccine Cold Supply Chain Can't Reach Everywhere
AQ
01/07JOHNSON & JOHNSON : Statement by Alex Gorsky Johnson & Johnson Chairman and CEO
AQ
01/05MORPHIC : Janssen Expand Collaboration on Integrin Program
MT
01/04JOHNSON & JOHNSON : Announces Quarterly Dividend for First Quarter 2021
PR
2020JOHNSON & JOHNSON : Large US Pharma Franchises on Track to Beat Credit Suisse's ..
MT
2020JOHNSON & JOHNSON : Zacks Adjusts Johnson & Johnson's Price Target to $161 from ..
MT
2020JOHNSON & JOHNSON : Janssen Submits European Marketing Authorisation Application..
AQ
2020JOHNSON & JOHNSON : Unit Files Marketing Application in Europe for Lung Cancer T..
MT
2020US Stocks Advance in Holiday-Shortened Trade With Treasuries After UK, EU Rea..
MT
2020GLOBAL MARKETS LIVE : Alibaba, Merck, Moderna…
2020MARKET CHATTER : South Korea Secures Pfizer, Johnson & Johnson COVID-19 Vaccines..
MT
2020JOHNSON & JOHNSON : Disease-Free Survival Data from CAPTIVATE Study Demonstrate ..
PU
2020JOHNSON & JOHNSON : Updated Results from the Phase 1 Study of the BCMAxCD3 Bispe..
PU
2020JOHNSON & JOHNSON : Early, Deep, Durable Responses of Ciltacabtagene Autoleucel ..
PU
2020JOHNSON & JOHNSON : to Participate in the 39th Annual J.P. Morgan Healthcare Con..
PU
2020JOHNSON & JOHNSON : New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibruti..
PU
2020JOHNSON & JOHNSON : Janssen Submits Application to U.S. FDA Seeking Approval of ..
PU
2020Pfizer In Talks With Malaysia for Additional Doses of COVID-19 Vaccine
MT
2020BIOSTOCK : Iconovo address maternal health in partnership with Monash University
AQ
2020GLOBAL MARKETS LIVE : Tesla, Bayer, Softbank...
2020JOHNSON & JOHNSON : Janssen Initiates Rolling Submission of a Biologics License ..
AQ
2020JOHNSON & JOHNSON : Announces Agreement in Principle with Gavi to Supply Janssen..
AQ
2020JOHNSON & JOHNSON : to Host Investor Conference Call on Fourth-Quarter Results
AQ
2020JOHNSON & JOHNSON : Janssen Initiates Rolling Submission of a Biologics License ..
PU
2020GlaxoSmithKline Unit Secures European Marketing Approval for Long-Acting Inje..
MT
2020ICONOVO : signs agreement for development of inhaled oxytocin in ICOone for mate..
AQ
2020JOHNSON & JOHNSON : Changing "Date Of Status" And "First Reported Date" May Expo..
AQ
2020ASSISTANT U.S. HEALTH SECRETARY GIROIR SAYS EXPECTS NEXT COVID VACCINE CANDID..
RE
2020JOHNSON & JOHNSON : WHO's COVID-19 vaccine drive doubles global supply to 2 bill..
AQ
2020JOHNSON & JOHNSON : to Host Investor Conference Call on Fourth-Quarter Results
PU
2020MACROGENICS : Enters Research Collaboration, License Agreement with J&J's Jansse..
MT
2020MACROGENICS : In Research, License Agreement With Janssen
DJ
2020JOHNSON & JOHNSON : Announces Its First Phase 3 COVID-19 Vaccine Trial ENSEMBLE ..
AQ
2020JOHNSON & JOHNSON : Completes Enrollment For Late-Stage Trial of COVID-19 Vaccin..
MT
2020JOHNSON & JOHNSON : Conference Chair from Johnson & Johnson Invites You to Atten..
AQ
2020JOHNSON & JOHNSON : Dow Jones, S&P 500 and Nasdaq Composite all hit record highs..
AQ
2020JOHNSON & JOHNSON : IP Rights Will Reduce Health Burden, Improve Economy, Expert..
AQ
2020Chile Approves Use of Pfizer's Covid-19 Vaccine
DJ
2020PROTAGONIST THERAPEUTICS : Commences Phase 1 Trial of Oral IL-23 Receptor Antago..
MT
2020XBRANE BIOPHARMA : Nina Ivers joins Xbrane Biopharma as Head of HR
AQ
2020JOHNSON & JOHNSON : Morgan Stanley Adjusts Price Target for Johnson & Johnson to..
MT
2020VERACYTE : Expands Partnership With Johnson & Johnson in Lung Cancer Detection S..
MT
2020JOHNSON & JOHNSON : to Participate in the 39th Annual J.P. Morgan Healthcare Con..
PU
2020Pfizer, BioNTech Covid-19 Vaccine Is Authorized in the U.S. -- 2nd Update
DJ
2020Pfizer, BioNTech Covid-19 Vaccine Is Authorized -2-
DJ
2020Pfizer, BioNTech Covid-19 Vaccine Is Authorized in the U.S. -- Update
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOHNSON & JOHNSON